LINCOLN, Neb. (KLKN) — Three former Nebraska Medicine CEOs signed a letter expressing their opposition to the proposed $800 million acquisition of Nebraska Medicine. The letter, dated Tuesday, is from former CEOs Glenn Fosdick (2002-2014), Dan DeBehnke (2016-2018), and James Linder (2018-2025) and expresses deep concern about the nearly billion-dollar purchase. “Leading an academic health system is complex, difficult work....
Espace publicitaire · 300×250
